Investment Analysts’ Updated EPS Estimates for June 8th (ADCT, ALL, ALLY, ARTV, AVAP, BB, BBUC, BBY, BEEM, BIIB)

Investment Analysts’ updated eps estimates for Monday, June 8th:

ADC Therapeutics (NYSE:ADCT) was downgraded by analysts at HC Wainwright from a buy rating to a neutral rating.

Allstate (NYSE:ALL) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. They currently have $242.00 price target on the stock.

Ally Financial (NYSE:ALLY) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Artiva Biotherapeutics (NASDAQ:ARTV) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $41.00 target price on the stock.

Avation (LON:AVAP) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 270 price target on the stock.

BlackBerry (NYSE:BB) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Brookfield Business (NYSE:BBUC) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Balfour Beatty (LON:BBY) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 985 price target on the stock.

Beam Global (NASDAQ:BEEM) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

Biogen (NASDAQ:BIIB) was upgraded by analysts at Needham & Company LLC from a hold rating to a buy rating. The firm currently has $255.00 target price on the stock.

Henry Boot (LON:BOOT) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 226 price target on the stock.

Blackstone Secured Lending Fund (NYSE:BXSL) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. The firm currently has $24.00 price target on the stock.

Cullinan Therapeutics (NASDAQ:CGEM) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $30.00 target price on the stock.

Chemed (NYSE:CHE) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Climb Bio (NASDAQ:CLYM) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $19.00 price target on the stock.

ConvaTec Group (LON:CTEC) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 300 target price on the stock.

Diageo (LON:DGE) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 2,000 price target on the stock.

Enersys (NYSE:ENS) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Entain (LON:ENT) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 1,000 price target on the stock.

Fate Therapeutics (NASDAQ:FATE) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $7.00 target price on the stock.

Flutter Entertainment (LON:FLTR) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a £160 price target on the stock.

L.B. Foster (NASDAQ:FSTR) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

StealthGas (NASDAQ:GASS) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

GSK (LON:GSK) had its hold rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 1,900 target price on the stock.

Helical (LON:HLCL) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 270 target price on the stock.

H World Group (NASDAQ:HTHT) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Humacyte (NASDAQ:HUMA) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $2.00 target price on the stock.

Keel Infrastructure (NASDAQ:KEEL) had its buy rating reaffirmed by analysts at Chardan Capital. Chardan Capital currently has a $5.50 price target on the stock.

Lyell Immunopharma (NASDAQ:LYEL) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $44.00 price target on the stock.

MGE Energy (NASDAQ:MGEE) was upgraded by analysts at LADENBURG THALM/SH SH from a neutral rating to a buy rating. The firm currently has $81.00 price target on the stock.

McGraw Hill (NYSE:MH) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $19.00 target price on the stock.

MoonLake Immunotherapeutics (NASDAQ:MLTX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $45.00 target price on the stock.

Moonpig Group (LON:MOON) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 315 target price on the stock.

Mpac Group (LON:MPAC) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd.

Mitie Group (LON:MTO) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 195 price target on the stock.

M.T.I Wireless Edge (LON:MWE) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 100 target price on the stock.

Nano Nuclear Energy (NASDAQ:NNE) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

Oric Pharmaceuticals (NASDAQ:ORIC) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $25.00 target price on the stock.

Pharos Energy (LON:PHAR) had its house stock rating reissued by analysts at Shore Capital Group Ltd. The firm currently has a GBX 38 target price on the stock.

Promis Neurosciences (NASDAQ:PMN) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $18.00 price target on the stock.

Strategic Education (NASDAQ:STRA) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Shattuck Labs (NASDAQ:STTK) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $18.00 target price on the stock.

TP ICAP Group (LON:TCAP) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 415 price target on the stock.

Tenable (NASDAQ:TENB) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

Tango Therapeutics (NASDAQ:TNGX) was upgraded by analysts at Wolfe Research from a peer perform rating to an outperform rating.

TRX Gold (NYSEAMERICAN:TRX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $2.30 target price on the stock.

Viking (NYSE:VIK) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.